NSE · AARTIPHARM
Aarti Pharmalabs Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#635
of 5,072 stocks
▲ 521W
Peak #635 · 27 Sep 2026
Aarti Pharmalabs Limited, a midcap Healthcare business, carries a steep earnings multiple that prices in strong future growth, is seeing revenue contract sharply, and posts a modest return on equity.
Market Cap
8,519.82 Cr
P/E Ratio
48.76
P/B Ratio
4.01
ROE
8.22%
ROCE
10.79%
Dividend Yield
0.16%
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 535.80 Cr | 582.64 Cr | 432.27 Cr | 418.33 Cr |
| Net Profit | 76.14 Cr | 61.12 Cr | 47.96 Cr | 27.92 Cr |
| EPS | 8.40 | 6.74 | 5.29 | 3.08 |
| Operating Profit | 106.53 Cr | 93.03 Cr | 73.32 Cr | 50.00 Cr |
Shareholding pattern
Promoter
42.86%
Public
57.14%
PUBLIC BREAKDOWN
FII
8.17%
DII
7.22%
MF (within DII)
0.79%
Individuals
36.08%
Mutual fund holdings
₹43.53
Cr total
9
Schemes
7
Fund Houses
₹43.53 Cr
Total Exposure
UTI Mutual Fund₹12.68 Cr (29.1%)
Motilal Oswal Mutual Fund₹11.44 Cr (26.3%)
WhiteOak Capital Mutual Fund₹9.89 Cr (22.7%)
HDFC Mutual Fund₹5.71 Cr (13.1%)
Taurus Mutual Fund₹3.72 Cr (8.5%)
Others₹0.09 Cr (0.2%)
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 16 Feb 2026 | Dividend | Interim Dividend - Rs 1.50 Per Share |
| 15 Sep 2025 | Dividend | Dividend - Rs 2.50 Per Share |
| 14 Feb 2025 | Dividend | Interim Dividend - Rs 2.50 Per Share |
| 31 Jul 2024 | Dividend | Dividend - Re 1 Per Share |
| 16 Feb 2024 | Dividend | Interim Dividend - Rs 2 Per Share |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.